SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors aggressively accumulate on dips, driven by anticipation surrounding the Clarity Act and ongoing institutional partnerships with major financial players. The community remains divided between long-term holders focusing on real-world payroll utility and skeptics reacting to daily price volatility and past performance.

Allora is a decentralized intelligence network that makes artificial intelligence more adaptive, collaborative, and efficient. The platform combines and coordinates thousands of specialized AI models in real time to produce superior inferences for users and applications. By enabling anyone to contribute models, data, or validation, Allora creates a self-improving market for intelligence that powers agents, DeFi systems, and AI applications across chains.

Allora

Allora is generating significant interest as traders debate its momentum and potential for a short squeeze following recent exchange volatility. Community sentiment remains polarized, with many highlighting the coin's low circulating supply and upcoming project announcements as key drivers for potential upside.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

Degen

DEGEN is capturing community attention as investors discuss potential ecosystem expansion, including new app developments and token burn initiatives aimed at boosting value. While some participants express caution regarding market volatility and previous price action, many are focused on the project's long-term utility and potential for broader exchange exposure.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is attracting significant attention as investors anticipate its expansion to the Ethereum mainnet and a potential broader market recovery. The community is actively discussing its role as a key liquidity hub on the Base chain, with many debating the sustainability of its token emissions model versus its potential for explosive growth.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Dominos Pizza is facing intense investor scrutiny as it navigates a challenging restaurant landscape defined by sluggish consumer discretionary spending and aggressive industry-wide price wars. Community discourse remains divided between those betting on long-term value through menu innovation and digital delivery partnerships and skeptics who fear the brand is losing its competitive edge to local rivals and shifting health trends.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing a surge in community engagement and price speculation, driven by anticipation of upcoming network upgrades and potential large-scale token burns. Traders and long-term holders are actively discussing recovery narratives and market momentum, with many looking toward the projects future potential despite past volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a late-breaking abstract presentation of Phase 2 axSpA data at the EULAR congress, which the community is interpreting as a 'best-in-class' signal. Investors are actively discussing the upcoming 52-week VELA trial results and the company's participation in the Goldman Sachs Healthcare Conference as critical catalysts that could drive a significant re-rating or trigger acquisition interest.

Canton Coin (CC), the network’s native utility token, was designed to reward real network usage over speculation. It aligns the success of the network with the participants who make it work, fairly rewarding app builders and app users, as well as those operating decentralized infrastructure. The result is a fundamentally different model where rewards flow to those creating value through real activity, not only miners or early investors.

Canton

Canton Network is gaining significant traction as a key infrastructure project for institutional finance, with major global payment companies joining as validators. The community is actively discussing its long-term potential in tokenized asset settlement, while closely monitoring token supply dynamics and exchange listing momentum.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is attracting intense investor interest as market participants speculate on potential acquisition interest and a short squeeze triggered by S&P index inclusion, while analysts highlight improved profitability and platform growth as core catalysts. The community is actively debating the company's valuation, questioning if the platform's long-term advertising and subscription momentum justifies a major breakout from current price levels.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing community attention as investors debate its long-term potential and relative performance against Bitcoin, with many closely tracking technical breakout levels and upcoming network upgrades. While some see the current price action as an accumulation opportunity ahead of anticipated market shifts, others remain skeptical, fueling intense discussion about its viability as a peer-to-peer electronic cash alternative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is the Options Market Predicting a Spike in Krystal Biotech Stock?

Investors need to pay close attention to KRYS stock based on the movements in the options market lately.

Why Is Techne (TECH) Up 4.5% Since Last Earnings Report?

Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Krystal Biotech Stock Soars 16% in Three Months: Here's Why

KRYS shares climb 16% in three months as Vyjuvek revenues jump 32%, pipeline programs advance and a nearly $1B cash pile fuels confidence.

Why Is Krystal Biotech (KRYS) Up 3% Since Last Earnings Report?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

KRYS shares jump after a Q1 beat as Vyjuvek fuels 32% revenue growth, strong uptake and global expansion, with pipeline catalysts lined up through 2026.

Krystal Biotech (NASDAQ:KRYS) Sets New 52-Week High After Better-Than-Expected Earnings

Krystal Biotech (NASDAQ:KRYS) Reaches New 12-Month High After Better-Than-Expected Earnings...

HC Wainwright Reiterates "Buy" Rating for Krystal Biotech (NASDAQ:KRYS)

HC Wainwright reissued a "buy" rating and issued a $310.00 price target on shares of Krystal Biotech in a research note on Monday...

Krystal Biotech Q1 Earnings Call Highlights

Krystal Biotech (NASDAQ:KRYS) reported first-quarter 2026 net revenue of $116.4 million from global sales of VYJUVEK, supported by continued demand in the U.S. and early traction in Europe and Japan. Management highlighted positive operating leverage, a 95% gross margin, and an expanding clinical pi...

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.79	--	--	N/A
Q1 '26	$1.49	$1.83	22.80%	BEAT
Q4 '25	$1.57	$1.70	8.49%	BEAT
Q3 '25	$1.09	$2.66	144.13%	BEAT
Q2 '25	$1.18	$1.29	8.88%	BEAT

KRYSKrystal Biotech Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest KRYS News